메뉴 건너뛰기




Volumn 15, Issue 2, 2016, Pages 164-169

Evaluation of CpG island methylator phenotype as a biomarker in colorectal cancer treated with adjuvant oxaliplatin

Author keywords

CIMP; Methylation; MSI; Prognosis; Survival

Indexed keywords

CACNA1G PROTEIN; CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; DNA; FLUOROURACIL; FOLINIC ACID; IGF2 PROTEIN; MESSENGER RNA; NEUROGENIN 1; OXALIPLATIN; PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; PLATINUM COMPLEX; TUMOR MARKER;

EID: 84950278034     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2015.10.005     Document Type: Article
Times cited : (24)

References (22)
  • 2
    • 77955277111 scopus 로고    scopus 로고
    • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis
    • W. De Roock, B. Claes, D. Bernasconi, and et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis Lancet Oncol 11 2010 753 762
    • (2010) Lancet Oncol , vol.11 , pp. 753-762
    • De Roock, W.1    Claes, B.2    Bernasconi, D.3
  • 3
    • 84881640407 scopus 로고    scopus 로고
    • Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication
    • P. Lochhead, A. Kuchiba, Y. Imamura, and et al. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication J Natl Cancer Inst 105 2013 1151 1156
    • (2013) J Natl Cancer Inst , vol.105 , pp. 1151-1156
    • Lochhead, P.1    Kuchiba, A.2    Imamura, Y.3
  • 4
    • 53049087109 scopus 로고    scopus 로고
    • Genomic and epigenetic instability in colorectal cancer pathogenesis
    • W.M. Grady, and J.M. Carethers Genomic and epigenetic instability in colorectal cancer pathogenesis Gastroenterology 135 2008 1079 1099
    • (2008) Gastroenterology , vol.135 , pp. 1079-1099
    • Grady, W.M.1    Carethers, J.M.2
  • 6
    • 0036242782 scopus 로고    scopus 로고
    • CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability
    • N. Hawkins, M. Norrie, K. Cheong, and et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability Gastroenterology 122 2002 1376 1387
    • (2002) Gastroenterology , vol.122 , pp. 1376-1387
    • Hawkins, N.1    Norrie, M.2    Cheong, K.3
  • 7
    • 34247570795 scopus 로고    scopus 로고
    • Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample
    • S. Ogino, T. Kawasaki, G.J. Kirkner, P. Kraft, M. Loda, and C.S. Fuchs Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample J Mol Diagn 9 2007 305 314
    • (2007) J Mol Diagn , vol.9 , pp. 305-314
    • Ogino, S.1    Kawasaki, T.2    Kirkner, G.J.3    Kraft, P.4    Loda, M.5    Fuchs, C.S.6
  • 8
    • 33745541234 scopus 로고    scopus 로고
    • CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
    • D.J. Weisenberger, K.D. Siegmund, M. Campan, and et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Nat Genet 38 2006 787 793
    • (2006) Nat Genet , vol.38 , pp. 787-793
    • Weisenberger, D.J.1    Siegmund, K.D.2    Campan, M.3
  • 9
    • 0036895068 scopus 로고    scopus 로고
    • Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
    • M. van Rijnsoever, F. Grieu, H. Elsaleh, D. Joseph, and B. Iacopetta Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands Gut 51 2002 797 802
    • (2002) Gut , vol.51 , pp. 797-802
    • Van Rijnsoever, M.1    Grieu, F.2    Elsaleh, H.3    Joseph, D.4    Iacopetta, B.5
  • 10
    • 79961137937 scopus 로고    scopus 로고
    • The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
    • B.H. Min, J.M. Bae, E.J. Lee, and et al. The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy BMC Cancer 11 2011 344
    • (2011) BMC Cancer , vol.11 , pp. 344
    • Min, B.H.1    Bae, J.M.2    Lee, E.J.3
  • 11
    • 84906935203 scopus 로고    scopus 로고
    • CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer
    • S. Shiovitz, M.M. Bertagnolli, L.A. Renfro, and et al. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer Gastroenterology 147 2014 637 645
    • (2014) Gastroenterology , vol.147 , pp. 637-645
    • Shiovitz, S.1    Bertagnolli, M.M.2    Renfro, L.A.3
  • 12
    • 84922879141 scopus 로고    scopus 로고
    • Association between molecular subtypes of colorectal cancer and patient survival
    • A.I. Phipps, P.J. Limburg, J.A. Baron, and et al. Association between molecular subtypes of colorectal cancer and patient survival Gastroenterology 148 2015 77 87.e72
    • (2015) Gastroenterology , vol.148 , pp. 77-87e72
    • Phipps, A.I.1    Limburg, P.J.2    Baron, J.A.3
  • 13
    • 0041524111 scopus 로고    scopus 로고
    • CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer
    • M. Van Rijnsoever, H. Elsaleh, D. Joseph, K. McCaul, and B. Iacopetta CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer Clin Cancer Res 9 2003 2898 2903
    • (2003) Clin Cancer Res , vol.9 , pp. 2898-2903
    • Van Rijnsoever, M.1    Elsaleh, H.2    Joseph, D.3    McCaul, K.4    Iacopetta, B.5
  • 14
    • 35948981194 scopus 로고    scopus 로고
    • Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy
    • L. Shen, P.J. Catalano, A.B. Benson III, P. O'Dwyer, S.R. Hamilton, and J.P. Issa Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy Clin Cancer Res 13 2007 6093 6098
    • (2007) Clin Cancer Res , vol.13 , pp. 6093-6098
    • Shen, L.1    Catalano, P.J.2    Benson, A.B.3    O'Dwyer, P.4    Hamilton, S.R.5    Issa, J.P.6
  • 15
    • 79953217628 scopus 로고    scopus 로고
    • 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer
    • R. Jover, T.P. Nguyen, L. Perez-Carbonell, and et al. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer Gastroenterology 140 2011 1174 1181
    • (2011) Gastroenterology , vol.140 , pp. 1174-1181
    • Jover, R.1    Nguyen, T.P.2    Perez-Carbonell, L.3
  • 16
    • 84874106654 scopus 로고    scopus 로고
    • Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
    • S.W. Han, H.J. Lee, J.M. Bae, and et al. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer Int J Cancer 132 2013 2209 2216
    • (2013) Int J Cancer , vol.132 , pp. 2209-2216
    • Han, S.W.1    Lee, H.J.2    Bae, J.M.3
  • 17
    • 85019194869 scopus 로고    scopus 로고
    • Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
    • D. Pectasides, V. Karavasilis, G. Papaxoinis, and et al. Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer BMC Cancer 15 2015 384
    • (2015) BMC Cancer , vol.15 , pp. 384
    • Pectasides, D.1    Karavasilis, V.2    Papaxoinis, G.3
  • 18
    • 69549108768 scopus 로고    scopus 로고
    • RNA extraction from archival formalin-fixed paraffin-embedded tissue: A comparison of manual, semiautomated, and fully automated purification methods
    • K. Bohmann, G. Hennig, U. Rogel, and et al. RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods Clin Chem 55 2009 1719 1727
    • (2009) Clin Chem , vol.55 , pp. 1719-1727
    • Bohmann, K.1    Hennig, G.2    Rogel, U.3
  • 19
    • 33744550591 scopus 로고    scopus 로고
    • Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis
    • S. Ogino, T. Kawasaki, M. Brahmandam, and et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis J Mol Diagn 8 2006 209 217
    • (2006) J Mol Diagn , vol.8 , pp. 209-217
    • Ogino, S.1    Kawasaki, T.2    Brahmandam, M.3
  • 20
    • 84929379762 scopus 로고    scopus 로고
    • Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: A prospective retrospective translational study in the context of a Hellenic Cooperative Oncology Group randomised trial
    • G. Pentheroudakis, G. Raptou, V. Kotoula, and et al. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a Hellenic Cooperative Oncology Group randomised trial PloS One 10 2015 e0124612
    • (2015) PloS One , vol.10 , pp. e0124612
    • Pentheroudakis, G.1    Raptou, G.2    Kotoula, V.3
  • 21
    • 64649096900 scopus 로고    scopus 로고
    • Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803
    • M.M. Bertagnolli, D. Niedzwiecki, C.C. Compton, and et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803 J Clin Oncol 27 2009 1814 1821
    • (2009) J Clin Oncol , vol.27 , pp. 1814-1821
    • Bertagnolli, M.M.1    Niedzwiecki, D.2    Compton, C.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.